Resultados de la búsqueda 21-30 de 4688 para Somatic

  1. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as intraoperative ...

  2. Neurología - Noticias de Mayo Clinic

    junio 2024. Mayo Clinic Minute: The link between heart disease and stroke June 05, 2024, 03:26 p.m. CDT · Mayo Clinic Minute: Testing gait to help in early ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to demonstrate non-inferior 12-month overall survival of patients with GlioblastomA (GBM) treated with dose escalated ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    All participants will undergo baseline screening for evidence of pre-stroke dementia. Those who pass baseline screening will complete a blood draw and a series ...

  6. Neurología - Ensayos clínicos - Mayo Clinic

    All participants will undergo baseline screening for evidence of pre-stroke dementia. Those who pass baseline screening will complete a blood draw and a series ...

  7. Oncología (médica) - Noticias de Mayo Clinic

    Oncología de Mayo Clinic: los oncólogos médicos de Mayo Clinic ofrecen tratamientos innovadores para el cáncer de órganos, huesos, músculos y tejidos ...

  8. Neurología - Ensayos clínicos - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to explore the translational abilities of desorption electrospray ionization mass spectrometry (DESI-MS) as intraoperative ...

  10. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to demonstrate non-inferior 12-month overall survival of patients with GlioblastomA (GBM) treated with dose escalated ...